Document Detail


Granulocyte colony-stimulating factor mediates cardioprotection against ischemia/reperfusion injury via phosphatidylinositol-3-kinase/Akt pathway in canine hearts.
MedLine Citation:
PMID:  16775664     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: Recent studies suggest that G-CSF prevents cardiac remodeling following myocardial infarction (MI) likely through regeneration of the myocardium and coronary vessels. However, it remains unclear whether G-CSF administered at the onset of reperfusion prevents ischemia/reperfusion injury in the acute phase. We investigated acute effects of G-CSF on myocardial infarct size and the incidence of lethal arrhythmia and evaluated the involvement of the phosphatidylinositol-3 kinase (PI3K) in the in vivo canine models. METHODS: In open-chest dogs, left anterior descending coronary artery (LAD) was occluded for 90 minutes followed by 6 hours of reperfusion. We intravenously administered G-CSF (0.33 micro/kg/min) for 30 minutes from the onset of reperfusion. Wortmannin, a PI3K inhibitor, was selectively administered into the LAD after the onset of reperfusion. RESULTS: G-CSF significantly (p<0.05) reduced myocardial infarct size (38.7+/-4.3% to 15.7+/-5.3%) and the incidence of ventricular fibrillation during reperfusion periods (50% to 0%) compared with the control. G-CSF enhanced Akt phospholylation in ischemic canine myocardium. Wortmannin blunted both the infarct size-limiting and anti-arrhythmic effects of G-CSF. G-CSF did not change myeloperoxidase activity, a marker of neutrophil accumulation, in the infarcted myocardium. CONCLUSION: An intravenous administration of G-CSF at the onset of reperfusion attenuates ischemia/reperfusion injury through PI3K/Akt pathway in the in vivo model. G-CSF administration can be a promising candidate for the adjunctive therapy for patients with acute myocardial infarction.
Authors:
Hiroyuki Takahama; Tetsuo Minamino; Akio Hirata; Akiko Ogai; Hiroshi Asanuma; Masashi Fujita; Masakatsu Wakeno; Osamu Tsukamoto; Ken-ichiro Okada; Kazuo Komamura; Seiji Takashima; Yoshiro Shinozaki; Hidezo Mori; Naoki Mochizuki; Masafumi Kitakaze
Related Documents :
1942094 - Effects of regional myocardial ischaemia on coronary artery calibre in the rabbit.
19744494 - Serca1 expression enhances the metabolic efficiency of improved contractility in post-i...
3587794 - Left and right ventricular function after streptokinase reperfusion: assessment by gate...
12870264 - Hemorrhagic transformation is related to the duration of occlusion and treatment with t...
9386164 - Metabolic response of normal human myocardium to high-dose atropine-dobutamine stress s...
10485594 - Hemofiltrate from patients with severe sepsis and depressed left ventricular contractil...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy     Volume:  20     ISSN:  0920-3206     ISO Abbreviation:  Cardiovasc Drugs Ther     Publication Date:  2006 Jun 
Date Detail:
Created Date:  2006-07-20     Completed Date:  2006-11-27     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  8712220     Medline TA:  Cardiovasc Drugs Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  159-65     Citation Subset:  IM    
Affiliation:
Department of Cardiovascular Medicine, National Cardiovascular Center, Suita, Osaka, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
1-Phosphatidylinositol 3-Kinase / physiology*
Animals
Dogs
Granulocyte Colony-Stimulating Factor / therapeutic use*
Myocardial Infarction / drug therapy*
Myocardial Reperfusion Injury / prevention & control*
Myocardium / metabolism
Peroxidase / metabolism
Proto-Oncogene Proteins c-akt / physiology*
Ventricular Fibrillation / drug therapy
Chemical
Reg. No./Substance:
143011-72-7/Granulocyte Colony-Stimulating Factor; EC 1.11.1.7/Peroxidase; EC 2.7.1.137/1-Phosphatidylinositol 3-Kinase; EC 2.7.11.1/Proto-Oncogene Proteins c-akt

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Lensing effects in a nematic liquid crystal with topological defects.
Next Document:  Different effects of adenosine and calcium channel blockade on myocardial no-reflow after acute myoc...